Statistics from Altmetric.com
Malnutrition in patients with cancer is a widely recognized problem. It has been shown to effect the response to surgery/chemotherapy and is associated with a poor performance status and a shortened survival.1 2 The extent of malnutrition can be classified as mild, moderate and severe based on several validated clinical scores.3 There is a lack of consensus and several societies have provided differing guidelines.4 Hence, the decision to provide enteral feeding in patients with cancer is complex and is based on several factors. The most important factor that needs to be considered is the therapeutic benefit and improvement in quality of life (QOL) for patients with cancer. Mucosal toxicity associated with the treatment of head and neck malignancies has been shown to contribute to a significant loss of body weight. The nutritional benefit and improvement of QOL by providing enteral nutrition during chemotherapy or concurrent chemoradiation therapy for head and neck cancers have been studied.5 6 Nutritional support by enteral feeding also appears to be associated with better outcomes in specific situations for aerodigestive …
Contributors All the authors equally contributed to the data acquisition, data analysis and manuscript writing.
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The study is based on a publicly available Federal database.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.